Bio-Inspired Nanocarriers Derived from Stem Cells and Their Extracellular Vesicles for Targeted Drug Delivery
暂无分享,去创建一个
Xiaolin Wang | Zhixiang Yuan | Yue Zhao | Tianqing Liu | Chengwei Wang | Munire Abudurexiti | Lu Han
[1] A. K. Mishra,et al. Nanotechnology in combating biofilm: A smart and promising therapeutic strategy , 2023, Frontiers in Microbiology.
[2] Zihui Gao,et al. Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[3] M. Ahmad,et al. Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives , 2023, 3 Biotech.
[4] Hangjun Xu,et al. Microvesicles as drug delivery systems: A new frontier for bionic therapeutics in cancer , 2022, Journal of Drug Delivery Science and Technology.
[5] Jianqing Gao,et al. Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system , 2022, Drug Delivery and Translational Research.
[6] Ronnie H. Fang,et al. Targeting drugs to tumours using cell membrane-coated nanoparticles , 2022, Nature reviews. Clinical oncology.
[7] Shixin Xu,et al. Stem Cell-derived Extracellular Vesicles: A Promising Nano Delivery Platform to the Brain? , 2022, Stem Cell Reviews and Reports.
[8] Junyong Wu,et al. Apoptotic bodies for advanced drug delivery and therapy. , 2022, Journal of controlled release : official journal of the Controlled Release Society.
[9] Michael R Hamblin,et al. Stem cell membrane-coated abiotic nanomaterials for biomedical applications. , 2022, Journal of controlled release : official journal of the Controlled Release Society.
[10] Weiyue Zhang,et al. Stem cell membrane-camouflaged targeted delivery system in tumor , 2022, Materials today. Bio.
[11] Xun Li,et al. Mesenchymal stem cells-based therapy in liver diseases , 2022, Molecular Biomedicine.
[12] M. Kamal,et al. Natural therapeutics and nutraceuticals for lung diseases: Traditional significance, phytochemistry, and pharmacology. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[13] M. Taheri,et al. Therapeutic Potential of Microvesicles in Cell Therapy and Regenerative Medicine of Ocular Diseases With an Especial Focus on Mesenchymal Stem Cells-Derived Microvesicles , 2022, Frontiers in Genetics.
[14] Zihua Wang,et al. Recent Advances in the Application of Mesenchymal Stem Cell-Derived Exosomes for Cardiovascular and Neurodegenerative Disease Therapies , 2022, Pharmaceutics.
[15] A. Al-Hendy,et al. Stem Cell Therapy: From Idea to Clinical Practice , 2022, International journal of molecular sciences.
[16] Yuan Zhong,et al. Cell membrane camouflaged biomimetic nanoparticles: Focusing on tumor theranostics , 2022, Materials today. Bio.
[17] G. Camussi. Exosomes and Microvesicles: from Stem Cell Biology to Translation in Human Diseases , 2022, Stem Cell Reviews and Reports.
[18] C. Vicinanza,et al. Modified mesenchymal stem cells in cancer therapy: A smart weapon requiring upgrades for wider clinical applications , 2022, World journal of stem cells.
[19] A. Conigliaro,et al. Molecular Mediators of RNA Loading into Extracellular Vesicles , 2021, Cells.
[20] A. Rizvanov,et al. Application of Mesenchymal Stem Cells Derived Artificial Microvesicles for the Treatment of Canine Skin Wound , 2021, BioNanoScience.
[21] Zhipeng Chen,et al. Research Progress on Cell Membrane-Coated Biomimetic Delivery Systems , 2021, Frontiers in Bioengineering and Biotechnology.
[22] Hongmei Liu,et al. Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy. , 2021, Colloids and surfaces. B, Biointerfaces.
[23] E. Tasciotti,et al. Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles , 2021, Nature Communications.
[24] D. Offen,et al. Intranasal delivery of mesenchymal stem cells‐derived extracellular vesicles for the treatment of neurological diseases , 2021, Stem cells.
[25] A. Shetty,et al. Extracellular Vesicles for the Diagnosis and Treatment of Parkinson’s Disease , 2021, Aging and disease.
[26] A. Goel,et al. The therapeutic triad of extracellular vesicles: As drug targets, as drugs, and as drug carriers. , 2021, Biochemical pharmacology.
[27] J. Ge,et al. Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment. , 2021, Biomaterials.
[28] Jiyong Liu,et al. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles , 2021, Drug delivery.
[29] Chunhong Li,et al. Recent advances in cell membrane-camouflaged nanoparticles for inflammation therapy , 2021, Drug delivery.
[30] Mayur M. Patel,et al. Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers , 2021, Nano-micro letters.
[31] C. Pollock,et al. Mesenchymal Stem Cell-Derived Extracellular Vesicles to the Rescue of Renal Injury , 2021, International journal of molecular sciences.
[32] S. Chauhan,et al. Nanotechnology based drug delivery system: Current strategies and emerging therapeutic potential for medical science , 2021, Journal of Drug Delivery Science and Technology.
[33] Nimit Shah,et al. Biomimetic Nanotechnology: A Natural Path Forward for Tumor-Selective and Tumor-Specific NIR Activable Photonanomedicines , 2021, Pharmaceutics.
[34] J. Baulch,et al. Human neural stem cell-derived extracellular vesicles mitigate hallmarks of Alzheimer’s disease , 2021, Alzheimer's Research & Therapy.
[35] A. Bertoni,et al. Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis , 2021, Stem Cell Reviews and Reports.
[36] S. Zheng,et al. Mesenchymal Stem Cell–Derived Exosomes: A Promising Biological Tool in Nanomedicine , 2021, Frontiers in Pharmacology.
[37] Nan Zhang,et al. Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics , 2021, Clinical and translational medicine.
[38] B. Joung,et al. Co-delivery of curcumin and miRNA-144-3p using heart-targeted extracellular vesicles enhances the therapeutic efficacy for myocardial infarction. , 2021, Journal of controlled release : official journal of the Controlled Release Society.
[39] Fei Liu,et al. Extracellular vesicle mimics made from iPS cell-derived mesenchymal stem cells improve the treatment of metastatic prostate cancer , 2021, Stem cell research & therapy.
[40] T. Webster,et al. Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery. , 2020, Biomaterials science.
[41] T. Iwasaki,et al. Cardiosphere-derived exosomal microRNAs for myocardial repair in pediatric dilated cardiomyopathy , 2020, Science Translational Medicine.
[42] S. Pacelli,et al. Investigation of human adipose stem cell-derived nanoparticles as a biomimetic carrier for intracellular drug delivery. , 2020, Nanoscale.
[43] R. Jafari,et al. Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine , 2020, Journal of translational medicine.
[44] S. Schwartz,et al. Extracellular Vesicles as Drug Delivery Systems in Cancer , 2020, Pharmaceutics.
[45] S. Schwartz,et al. The potential of nanomedicine to alter cancer stem cell dynamics: the impact of extracellular vesicles. , 2020, Nanomedicine.
[46] M. Vallet‐Regí,et al. Nanoparticles Coated with Cell Membranes for Biomedical Applications , 2020, Biology.
[47] M. Nishikawa,et al. Anticancer drug-loaded mesenchymal stem cells for targeted cancer therapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[48] R. Shi,et al. Mesenchymal stem cell-derived exosomes: Hope for spinal cord injury repair. , 2020, Stem cells and development.
[49] Wuli Yang,et al. Highly biosafe biomimetic stem cell membrane-disguised nanovehicles for cartilage regeneration. , 2020, Journal of materials chemistry. B.
[50] Wei Huang,et al. Recent advances in drug delivery systems for targeting cancer stem cells , 2020, Acta pharmaceutica Sinica. B.
[51] S. Yamanaka. Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges. , 2020, Cell stem cell.
[52] S. Mohsin,et al. Role of Stem Cell Derived Microvesicles in Cardiovascular Disease. , 2020, Journal of cardiovascular pharmacology.
[53] H. Barrera-Saldana,et al. Mesenchymal Stem Cells Current Clinical Applications: A Systematic Review. , 2020, Archives of medical research.
[54] A. Piras,et al. Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[55] T. K. Phan,et al. Unleashing the therapeutic potential of apoptotic bodies , 2020, Biochemical Society transactions.
[56] C. Tirolo,et al. Extracellular Vesicles as Nanotherapeutics for Parkinson’s Disease , 2020, Biomolecules.
[57] D. Offen,et al. Promising Opportunities for Treating Neurodegenerative Diseases with Mesenchymal Stem Cell-Derived Exosomes , 2020, Biomolecules.
[58] Yueqiu Chen,et al. HIF-1α overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis , 2020, Stem Cell Research & Therapy.
[59] Xuexi Wang,et al. Mesenchymal stem cell-derived exosomes: Toward cell-free therapeutic strategies in regenerative medicine , 2020, World journal of stem cells.
[60] A. E. Elçin,et al. Therapeutic Applications of Stem Cells and Extracellular Vesicles in Emergency Care: Futuristic Perspectives , 2020, Stem Cell Reviews and Reports.
[61] Jun Yang,et al. Exosome: a significant nano-scale drug delivery carrier. , 2020, Journal of materials chemistry. B.
[62] Bin Wang,et al. Extracellular vesicle-based Nanotherapeutics: Emerging frontiers in anti-inflammatory therapy , 2020, Theranostics.
[63] U. Galderisi,et al. Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia?☆ , 2020, Journal of Controlled Release.
[64] Cuifeng Wang,et al. Proinflammatory macrophage-derived microvesicles exhibit tumor tropism dependent on CCL2/CCR2 signaling axis and promote drug delivery via SNARE-mediated membrane fusion , 2020, Theranostics.
[65] G. Camussi,et al. Nephroprotective Potential of Mesenchymal Stromal Cells and Their Extracellular Vesicles in a Murine Model of Chronic Cyclosporine Nephrotoxicity , 2020, Frontiers in Cell and Developmental Biology.
[66] D. Torella,et al. Unravelling the Biology of Adult Cardiac Stem Cell-Derived Exosomes to Foster Endogenous Cardiac Regeneration and Repair , 2020, International journal of molecular sciences.
[67] B. Ahn,et al. Extracellular Vesicle- and Extracellular Vesicle Mimetics-Based Drug Delivery Systems: New Perspectives, Challenges, and Clinical Developments , 2020, Pharmaceutics.
[68] R. Schiffelers,et al. Extracellular vesicles as drug delivery systems: Why and how? , 2020, Advanced drug delivery reviews.
[69] Xiuying Wang,et al. Chitosan modified Fe3O4/KGN self-assembled nanoprobes for osteochondral MR diagnose and regeneration , 2020, Theranostics.
[70] L. Suggs,et al. Modulating inflammatory macrophages with an apoptotic body-inspired nanoparticle. , 2020, Acta biomaterialia.
[71] C. Balistreri,et al. Stem cell therapy: old challenges and new solutions , 2020, Molecular Biology Reports.
[72] G. Faggian,et al. Exosomes: From Potential Culprits to New Therapeutic Promise in the Setting of Cardiac Fibrosis , 2020, Cells.
[73] Jinli Wang,et al. MiR-101a loaded Extracellular Nanovesicles as Bioactive Carriers for Cardiac Repair , 2020, bioRxiv.
[74] Chao Wang,et al. Cell membrane-coated nanoparticles: research advances. , 2020, Nanomedicine.
[75] D. He,et al. Cell Membrane-camouflaged Nanoparticles as Drug Carriers for Cancer Therapy. , 2020, Acta biomaterialia.
[76] Zhiwei Sun,et al. Personalized detection of circling exosomal PD-L1 based on Fe3O4@TiO2 isolation and SERS immunoassay. , 2020, Biosensors & bioelectronics.
[77] Lesley Cheng,et al. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles. , 2020, Methods.
[78] Ling Li,et al. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source , 2020, Drug delivery.
[79] E. Falcieri,et al. Apoptotic Bodies: Particular Extracellular Vesicles Involved in Intercellular Communication , 2020, Biology.
[80] M. Alcaraz,et al. Extracellular Vesicles from Mesenchymal Stem Cells as Novel Treatments for Musculoskeletal Diseases , 2019, Cells.
[81] J. Xu,et al. Biomimetic nanovesicles made from iPS cell-derived mesenchymal stem cells for targeted therapy of triple-negative breast cancer. , 2019, Nanomedicine : nanotechnology, biology, and medicine.
[82] Jenna A. Dombroski,et al. Engineering of Exosomes to Target Cancer Metastasis , 2019, Cellular and Molecular Bioengineering.
[83] J. Devoisselle,et al. Post-production modifications of murine mesenchymal stem cell (mMSC) derived extracellular vesicles (EVs) and impact on their cellular interaction. , 2019, Biomaterials.
[84] E. Tasciotti,et al. Exosome-like nanovectors for drug delivery in cancer. , 2019, Current medicinal chemistry.
[85] Jee‐Heon Jeong,et al. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives. , 2019, European journal of cell biology.
[86] U. Armato,et al. Mesenchymal stromal cells-exosomes: a promising cell-free therapeutic tool for wound healing and cutaneous regeneration , 2019, Burns & Trauma.
[87] J. Colacino,et al. Environmental exposures, stem cells, and cancer. , 2019, Pharmacology & therapeutics.
[88] Y. Gho,et al. Embryonic stem cell-derived extracellular vesicle-mimetic nanovesicles rescue erectile function by enhancing penile neurovascular regeneration in the streptozotocin-induced diabetic mouse , 2019, Scientific Reports.
[89] J. Whitelegge,et al. Extracellular Vesicles From Auditory Cells as Nanocarriers for Anti-inflammatory Drugs and Pro-resolving Mediators , 2019, Front. Cell. Neurosci..
[90] A. Fernandez-Gonzalez,et al. Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes. , 2019, JCI insight.
[91] J. Simpson,et al. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[92] Yanbo Zhang,et al. Mesenchymal Stem Cells for Regenerative Medicine , 2019, Cells.
[93] G. Pastorin,et al. Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers , 2019, International journal of molecular sciences.
[94] Thierry Burnouf,et al. Extracellular Microvesicles as New Industrial Therapeutic Frontiers. , 2019, Trends in biotechnology.
[95] Xiaobing Fu,et al. Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases , 2019, Stem Cell Research & Therapy.
[96] Methichit Wattanapanitch. Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders , 2019, Stem cells international.
[97] Roger M. Ilagan,et al. Mesenchymal stromal cell-derived exosomes improve mitochondrial health in pulmonary arterial hypertension. , 2019, American journal of physiology. Lung cellular and molecular physiology.
[98] A. Hill,et al. Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications , 2019, Journal of extracellular vesicles.
[99] Haiyang Hu,et al. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges. , 2019, Journal of materials chemistry. B.
[100] Xuan Sun,et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization , 2019, Cardiovascular research.
[101] Xin Niu,et al. Embryonic Stem Cells‐Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy , 2019, Advanced science.
[102] Yoshimi Yashiro,et al. Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development. , 2019, Physiological reviews.
[103] Y. Tabata,et al. Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic. , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[104] S. Antimisiaris,et al. Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery , 2018, Pharmaceutics.
[105] Wei Wang,et al. Recent advancements in the use of exosomes as drug delivery systems , 2018, Journal of Nanobiotechnology.
[106] L. Ramenghi,et al. Microvesicles as promising biological tools for diagnosis and therapy , 2018, Expert review of proteomics.
[107] L. Gentile,et al. A complete workflow for the differentiation and the dissociation of hiPSC-derived cardiospheres. , 2018, Stem Cell Research.
[108] Shunliang Xu,et al. Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate Neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating Microglial Activation in Alzheimer’s Disease , 2018, Neurochemical Research.
[109] S. Jeong,et al. A New Approach for Loading Anticancer Drugs Into Mesenchymal Stem Cell-Derived Exosome Mimetics for Cancer Therapy , 2018, Front. Pharmacol..
[110] Xuan Sun,et al. Intravenous mesenchymal stem cell-derived exosomes ameliorate myocardial inflammation in the dilated cardiomyopathy. , 2018, Biochemical and biophysical research communications.
[111] S. Shi,et al. Circulating apoptotic bodies maintain mesenchymal stem cell homeostasis and ameliorate osteopenia via transferring multiple cellular factors , 2018, Cell Research.
[112] David Tareste,et al. Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems. , 2018, ACS nano.
[113] Hua Han,et al. Stem cells: a promising candidate to treat neurological disorders , 2018, Neural regeneration research.
[114] M. Y. Thanuja,et al. Bioengineered cellular and cell membrane‐derived vehicles for actively targeted drug delivery: So near and yet so far , 2018, Advanced drug delivery reviews.
[115] Liang Xie,et al. Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application , 2018, Stem cells international.
[116] Ronnie H. Fang,et al. Cell Membrane Coating Nanotechnology , 2018, Advanced materials.
[117] Xiujie Wang,et al. Emerging role of exosome signalling in maintaining cancer stem cell dynamic equilibrium , 2018, Journal of cellular and molecular medicine.
[118] Jianping Zhou,et al. Bio-inspired drug delivery systems: an emerging platform for targeted cancer therapy. , 2018, Biomaterials science.
[119] Ronghu Wu,et al. Extracellular vesicles from bone marrow-derived mesenchymal stromal cells support ex vivo survival of human antibody secreting cells , 2018, Journal of extracellular vesicles.
[120] M. Ghahremani,et al. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine , 2018, Stem Cell Research & Therapy.
[121] Hong Tang,et al. Stem Cells Transplantation in the Treatment of Patients with Liver Failure. , 2018, Current stem cell research & therapy.
[122] Junhua Wu,et al. Exosome-Mimetic Nanovesicles from Hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo , 2018, Scientific Reports.
[123] Hakho Lee,et al. New Technologies for Analysis of Extracellular Vesicles. , 2018, Chemical reviews.
[124] T. Meulia,et al. Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model , 2018, Stem Cell Research & Therapy.
[125] Graça Raposo,et al. Shedding light on the cell biology of extracellular vesicles , 2018, Nature Reviews Molecular Cell Biology.
[126] Carmen Pazos,et al. Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes , 2018, Journal of extracellular vesicles.
[127] M. Stojkovic,et al. Ethical and Safety Issues of Stem Cell-Based Therapy , 2018, International journal of medical sciences.
[128] Robert J. Vincent,et al. Induced Pluripotent Stem Cell (iPSC)–Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs , 2017, Circulation research.
[129] S. Bicciato,et al. Regeneration of the entire human epidermis using transgenic stem cells , 2017, Nature.
[130] L. V. Van Laake,et al. Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology , 2017, Cardiovascular research.
[131] J. Sánchez-Alcázar,et al. Dynamic Reorganization of the Cytoskeleton during Apoptosis: The Two Coffins Hypothesis , 2017, International journal of molecular sciences.
[132] S. Kourembanas,et al. Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency , 2017, Front. Cardiovasc. Med..
[133] J. Wojtkiewicz,et al. The Use of Adipose-Derived Stem Cells in Selected Skin Diseases (Vitiligo, Alopecia, and Nonhealing Wounds) , 2017, Stem cells international.
[134] Nupur Basu,et al. Hyaluronic acid coatings as a simple and efficient approach to improve MSC homing toward the site of inflammation , 2017, Scientific Reports.
[135] Joseph C. Wu,et al. Comparison of Non‐Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell‐ versus Induced Pluripotent Stem Cell‐Derived Cardiomyocytes , 2017, Stem cells.
[136] Oh Youn Kim,et al. Extracellular vesicle mimetics: Novel alternatives to extracellular vesicle-based theranostics, drug delivery, and vaccines. , 2017, Seminars in cell & developmental biology.
[137] T. Kanjevac,et al. Nanoparticles in Antiviral Therapy , 2017, Antimicrobial Nanoarchitectonics.
[138] Lanjuan Li,et al. Role of mesenchymal stem cells, their derived factors, and extracellular vesicles in liver failure , 2017, Stem Cell Research & Therapy.
[139] Mario Gimona,et al. Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use , 2017, International journal of molecular sciences.
[140] Yanning Liu,et al. MiR‐122 modification enhances the therapeutic efficacy of adipose tissue‐derived mesenchymal stem cells against liver fibrosis , 2017, Journal of cellular and molecular medicine.
[141] Gang Liu,et al. Nanobiotechnology: Cell Membrane-Based Delivery Systems. , 2017, Nano today.
[142] N. Khanlarkhani,et al. Multipotent Stem Cell and Current Application. , 2017, Acta medica Iranica.
[143] Hongguang Zhang,et al. hucMSC Exosome-Derived GPX1 Is Required for the Recovery of Hepatic Oxidant Injury. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[144] G. Angelini,et al. Human Pericardial Fluid Contains Exosomes Enriched with Cardiovascular-Expressed MicroRNAs and Promotes Therapeutic Angiogenesis , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[145] R. Califf,et al. Clarifying Stem-Cell Therapy's Benefits and Risks. , 2016, The New England journal of medicine.
[146] A. Lendlein,et al. Nanocarriers for drug delivery into and through the skin - Do existing technologies match clinical challenges? , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[147] Pieter Vader,et al. Extracellular vesicles for drug delivery. , 2016, Advanced drug delivery reviews.
[148] H. T. Park,et al. RNAi delivery by exosome-mimetic nanovesicles - Implications for targeting c-Myc in cancer. , 2016, Biomaterials.
[149] J. Seghatchian,et al. Update on extracellular vesicles inside red blood cell storage units: Adjust the sails closer to the new wind. , 2016, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[150] R. Mahla. Stem Cells Applications in Regenerative Medicine and Disease Therapeutics , 2016, International journal of cell biology.
[151] U. Galderisi,et al. Clinical Trials with Mesenchymal Stem Cells: An Update , 2016, Cell transplantation.
[152] Juliane Nguyen,et al. Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[153] R. Schiffelers,et al. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[154] F. Wendler,et al. Extracellular vesicles round off communication in the nervous system , 2016, Nature Reviews Neuroscience.
[155] S. Mayor,et al. GPI-anchored protein organization and dynamics at the cell surface , 2016, Journal of Lipid Research.
[156] S. Redenti,et al. Characterization of Induced Pluripotent Stem Cell Microvesicle Genesis, Morphology and Pluripotent Content , 2016, Scientific Reports.
[157] Roberto Mayor,et al. The front and rear of collective cell migration , 2016, Nature Reviews Molecular Cell Biology.
[158] A. Hill,et al. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey , 2016, Journal of extracellular vesicles.
[159] Sahil D. Shah,et al. Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. , 2015, Methods.
[160] Mohsin Khan,et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. , 2015, Circulation research.
[161] Richa Gupta,et al. Exosomes as drug delivery vehicles for Parkinson's disease therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[162] Kelly Aubertin,et al. Combining magnetic nanoparticles with cell derived microvesicles for drug loading and targeting. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[163] C. Emiliani,et al. Exosome-based strategies for Diagnosis and Therapy. , 2015, Recent patents on CNS drug discovery.
[164] A. Lloyd,et al. Nanoprecipitation of polymeric nanoparticle micelles based on 2-methacryloyloxyethyl phosphorylcholine (MPC) with 2-(diisopropylamino)ethyl methacrylate (DPA), for intracellular delivery applications , 2015, Journal of Materials Science: Materials in Medicine.
[165] Cecilia Lässer. Exosomes in diagnostic and therapeutic applications: biomarker, vaccine and RNA interference delivery vehicle , 2015, Expert opinion on biological therapy.
[166] Imre Mäger,et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting , 2015, Journal of extracellular vesicles.
[167] Andrew F. Hill,et al. Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper , 2015, Journal of extracellular vesicles.
[168] L. O’Driscoll,et al. Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.
[169] A. Bahrami,et al. Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy , 2015, Cell biology international.
[170] Eoin P. McNeill,et al. MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs , 2014, Proceedings of the National Academy of Sciences.
[171] Jamie R. Lead,et al. Quantitative measurement of the nanoparticle size and number concentration from liquid suspensions by atomic force microscopy. , 2014, Environmental science. Processes & impacts.
[172] Jian Song,et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.
[173] N. Tyagi,et al. Exosomes: Mediators of Neurodegeneration, Neuroprotection and Therapeutics , 2014, Molecular Neurobiology.
[174] A. Tedgui,et al. Microvesicles as Cell–Cell Messengers in Cardiovascular Diseases , 2014, Circulation research.
[175] Andrew F. Hill,et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles , 2014, Journal of extracellular vesicles.
[176] R. Nieuwland,et al. Single-step isolation of extracellular vesicles by size-exclusion chromatography , 2014, Journal of extracellular vesicles.
[177] M. Chopp,et al. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[178] Seok-Goo Cho,et al. Clinical applications of mesenchymal stem cells , 2013, The Korean journal of internal medicine.
[179] J. Leonard,et al. FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver , 2013, Pharmaceuticals.
[180] S. Lim,et al. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. , 2013, Advanced drug delivery reviews.
[181] Graça Raposo,et al. Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.
[182] Yu Xin Wang,et al. The emerging biology of muscle stem cells: Implications for cell-based therapies , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.
[183] W. Stoorvogel,et al. Identification of Distinct Populations of Prostasomes That Differentially Express Prostate Stem Cell Antigen, Annexin A1, and GLIPR2 in Humans1 , 2012, Biology of reproduction.
[184] D. Hwang,et al. Proteomic analysis of microvesicles derived from human mesenchymal stem cells. , 2012, Journal of proteome research.
[185] Dongmei Sun,et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[186] M. Wood,et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.
[187] Manuel T. Silva. Secondary necrosis: The natural outcome of the complete apoptotic program , 2010, FEBS letters.
[188] Luigi Biancone,et al. Exosomes/microvesicles as a mechanism of cell-to-cell communication. , 2010, Kidney international.
[189] M. Zöller,et al. CD44v6 dependence of premetastatic niche preparation by exosomes. , 2009, Neoplasia.
[190] Carolyn R Bertozzi,et al. Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. , 2009, Angewandte Chemie.
[191] Alessandro Busca,et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. , 2009, Journal of the American Society of Nephrology : JASN.
[192] V. Nurcombe,et al. Wnt signaling controls the fate of mesenchymal stem cells. , 2009, Gene.
[193] Jacopo Meldolesi,et al. Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.
[194] A. Uccelli,et al. Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.
[195] R. Young,et al. Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming , 2008, Cell.
[196] S. Elmore. Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.
[197] M. Record,et al. Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. , 2007, Biochimie.
[198] O. Lindvall,et al. Stem cells for the treatment of neurological disorders , 2006, Nature.
[199] S. Perez,et al. Characterization of the Optimal Culture Conditions for Clinical Scale Production of Human Mesenchymal Stem Cells , 2006, Stem cells.
[200] Anna Janowska-Wieczorek,et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer , 2005, International journal of cancer.
[201] Aled Clayton,et al. Antigen‐presenting cell exosomes are protected from complement‐mediated lysis by expression of CD55 and CD59 , 2003, European journal of immunology.
[202] J. Le Pecq,et al. Production and characterization of clinical grade exosomes derived from dendritic cells. , 2002, Journal of immunological methods.
[203] Y. Lo,et al. Stability of endogenous and added RNA in blood specimens, serum, and plasma. , 2002, Clinical chemistry.
[204] Y. Ueno,et al. The process of ultrastructural changes from nuclei to apoptotic body , 1998, Virchows Archiv.
[205] Jiacan Su,et al. Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy , 2022, Extracellular Vesicles and Circulating Nucleic Acids.
[206] Gong Cheng,et al. Aptamer-Conjugated Extracellular Nanovesicles for Targeted Drug Delivery. , 2018, Cancer research.
[207] Lily Yang,et al. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer. , 2018, Biomaterials.
[208] R. Menon,et al. Placental Exosomes During Gestation: Liquid Biopsies Carrying Signals for the Regulation of Human Parturition. , 2018, Current pharmaceutical design.
[209] Xiaohong Wang,et al. Pathologic function and therapeutic potential of exosomes in cardiovascular disease. , 2015, Biochimica et biophysica acta.
[210] Mahendra S Rao,et al. A review of the methods for human iPSC derivation. , 2013, Methods in molecular biology.
[211] J. P. Lopes,et al. [Mesenchymal stem cell therapy in heart disease]. , 2013, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[212] Gupta Manish,et al. Targeted drug delivery system: A Review , 2011 .
[213] C. Fong,et al. Human Embryonic Stem Cells: Their Nature, Properties, and Uses , 2009 .